Selected article for: "adverse effect and present study"
Author: Mohammed, Abdul; Paranji, Neethi; Chen, Po-Hung; Niu, Bolin
Title: COVID-19 in Chronic Liver Disease and Liver Transplantation: A Clinical Review
  • Cord-id: wbvxlbfz
  • Document date: 2020_12_24
    • ID: wbvxlbfz
    Snippet: The coronavirus disease 2019 (COVID-19) pandemic has brought challenges to clinicians caring for patients with chronic liver disease. In the past 6 months, COVID-19 has led to over 150,000 deaths in the United States and over 660,000 deaths around the world. Mounting evidence suggests that chronic liver diseases can have an adverse effect on the clinical outcomes of patients with COVID-19. We present a comprehensive review of the latest literature on preexisting liver diseases and its interrelat
    Document: The coronavirus disease 2019 (COVID-19) pandemic has brought challenges to clinicians caring for patients with chronic liver disease. In the past 6 months, COVID-19 has led to over 150,000 deaths in the United States and over 660,000 deaths around the world. Mounting evidence suggests that chronic liver diseases can have an adverse effect on the clinical outcomes of patients with COVID-19. We present a comprehensive review of the latest literature on preexisting liver diseases and its interrelationship with COVID-19 infection in cirrhosis, hepatocellular carcinoma, nonalcoholic fatty liver disease, autoimmune hepatitis, and viral hepatitis B. As social distancing and telemedicine gain new footing, we synthesize recommendations from 3 major hepatology societies [American Association for the Study of Liver Disease (AASLD), the European Association for the Study of Liver (EASL), and the Asian Pacific Association for the Study of Liver (APASL)] to present the best approaches for caring for patients with liver diseases as well as those requiring liver transplantation.

    Search related documents:
    Co phrase search for related documents
    • liver disease and low sensitivity: 1, 2
    • liver disease and lt chronic liver disease: 1
    • liver disease and lt liver transplantation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
    • liver disease and lt patient: 1, 2, 3, 4
    • liver disease and lt recipient: 1, 2
    • liver injury and locoregional therapy: 1
    • liver injury and long duration: 1
    • liver injury and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • liver injury and low sensitivity: 1, 2
    • liver injury and lt liver transplantation: 1, 2, 3, 4
    • liver injury and m1 macrophage: 1
    • liver injury patient and lopinavir ritonavir: 1, 2, 3
    • liver injury report and lopinavir ritonavir: 1